News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Amyris Raises $84.8M in IPO, Prices at $16, Well Below Expected Range



9/28/2010 7:06:57 AM

NEW YORK, Sept 27 (Reuters) - Amyris Inc (AMRS.O), which uses yeast to convert plant sugars into the building blocks of anti-malarial drugs, priced shares in its initial public offering below the range on Monday, according to an underwriter.

Read at News Release
Read at Wall Street Journal
Read at Forbes
Read at Reuters


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES